HIV Citation List: April 01, 2011 - April 14, 2011
Pubmed citations:
1. Synthesis and Biological Evaluation of Fatty Acyl Ester Derivatives of 2',3'-Didehydro-2',3'-dideoxythymidine. Agarwal, H.K., K. Loethan, D. Mandal, G.F. Doncel, and K. Parang. Bioorganic & Medicinal Chemistry Letters, 2011. 21(7): p. 1917-1921; PMID[21382714].
[Pubmed], HIV_0401-041410.
2. Synthesis of 9-Substituted Derivatives of Berberine as Anti-HIV Agents. Bodiwala, H.S., S. Sabde, D. Mitra, K.K. Bhutani, and I.P. Singh. European Journal of Medicinal Chemistry, 2011. 46(4): p. 1045-1049; PMID[21295891].
[Pubmed], HIV_0401-041410.
3. In Vitro Characterization of Gs-8374, a Novel Phosphonate-Containing Inhibitor of HIV-1 Protease with a Favorable Resistance Profile. Callebaut, C., K. Stray, L. Tsai, M. Williams, Z.Y. Yang, C. Cannizzaro, S.A. Leavitt, X. Liu, K. Wang, B.P. Murray, A. Mulato, M. Hatada, T. Priskich, N. Parkin, S. Swaminathan, W. Lee, G.X. He, L. Xu, and T. Cihlar. Antimicrobial Agents and Chemotherapy, 2011. 55(4): p. 1366-1376; PMID[21245449].
[Pubmed], HIV_0401-041410.
4. Hormonally Active Vitamin D3 (1{Alpha},25-Dihydroxycholecalciferol) Triggers Autophagy in Human Macrophages That Inhibits HIV-1 Infection. Campbell, G.R. and S.A. Spector. Journal of Biological Chemistry, 2011. [Epub ahead of print]; PMID[21454634].
[Pubmed], HIV_0401-041410.
5. The Absolute Configuration of Anti-HIV-1 Agent (-)-Concentricolide : Total Synthesis of (+)-(R)-Concentricolide. Chang, C.W. and R.J. Chein. The Journal of Organic Chemistry, 2011. [Epub ahead of print]; PMID[21462994].
[Pubmed], HIV_0401-041410.
6. Advances of Research on Anti-HIV Agents from Traditional Chinese Herbs. Chu, Y. and H. Liu. Advances in Dental Research, 2011. 23(1): p. 67-75; PMID[21441484].
[Pubmed], HIV_0401-041410.
7. Down-Regulation of HIV-1 Infection by Inhibition of the Mapk Signaling Pathway. Gong, J., X.H. Shen, C. Chen, H. Qiu, and R.G. Yang. Virologica Sinica, 2011. 26(2): p. 114-122; PMID[21468934].
[Pubmed], HIV_0401-041410.
8. Activation of Latent Hiv Using Drug-Loaded Nanoparticles. Kovochich, M., M.D. Marsden, and J.A. Zack. PLoS One, 2011. 6(4): p. e18270; PMID[21483687].
[Pubmed], HIV_0401-041410.
9. Imaging-Based Assay for Identification and Characterization of Inhibitors of Cxcr4-Tropic HIV-1 Envelope-Dependent Cell-Cell Fusion. Kramer, S., P. Buontempo, S. Agrawal, and R. Ralston. Journal of Biomolecular Screening, 2011. [Epub ahead of print]; PMID[21474836].
[Pubmed], HIV_0401-041410.
10. Rhodium(II) Acetate-Catalyzed Stereoselective Synthesis, SAR and Anti-HIV Activity of Novel Oxindoles Bearing Cyclopropane Ring. Kumari, G., Nutan, M. Modi, S.K. Gupta, and R.K. Singh. European Journal of Medicinal Chemistry, 2011. 46(4): p. 1181-1188; PMID[21339030].
[Pubmed], HIV_0401-041410.
11. Phenotypic Characterization of Drug Resistance-Associated Mutations in HIV-1 Rt Connection and Rnase H Domains and Their Correlation with Thymidine Analogue Mutations. Lengruber, R.B., K.A. Delviks-Frankenberry, G.N. Nikolenko, J. Baumann, A.F. Santos, V.K. Pathak, and M.A. Soares. Journal of Antimicrobial Chemotherapy, 2011. 66(4): p. 702-708; PMID[21393163].
[Pubmed], HIV_0401-041410.
12. Synthesis and Anti-HIV-1 Activity of New Fluoro-Hept Analogues: An Investigation on Fluoro Versus Hydroxy Substituents. Loksha, Y.M., E.B. Pedersen, R. Loddo, and P. La Colla. Archiv der Pharmazie (Weinheim), 2011. [Epub ahead of print]; PMID[21456073].
[Pubmed], HIV_0401-041410.
13. Vaginal Microbicide Gel for Delivery of Iqp-0528, a Pyrimidinedione Analog with a Dual Mechanism of Action against HIV-1. Mahalingam, A., A.P. Simmons, S.R. Ugaonkar, K.M. Watson, C.S. Dezzutti, L.C. Rohan, R.W. Buckheit, Jr., and P.F. Kiser. Antimicrobial Agents and Chemotherapy, 2011. 55(4): p. 1650-1660; PMID[21245437].
[Pubmed], HIV_0401-041410.
14. Impact of the N348i Mutation in HIV-1 Reverse Transcriptase on Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Non-Subtype B HIV-1. McCormick, A.L., C.M. Parry, A. Crombe, R.L. Goodall, R.K. Gupta, P. Kaleebu, C. Kityo, M. Chirara, G.J. Towers, and D. Pillay. Antimicrobial Agents and Chemotherapy, 2011. 55(4): p. 1806-1809; PMID[21282419].
[Pubmed], HIV_0401-041410.
15. HIV Integrase Variability and Genetic Barrier in Antiretroviral Naive and Experienced Patients. Piralla, A., S. Paolucci, R. Gulminetti, G. Comolli, and F. Baldanti. Virology Journal, 2011. 8(1): p. 149; PMID[21453487].
[Pubmed], HIV_0401-041410.
16. High Mannose-Binding Lectin with Preference for the Cluster of {Alpha}1-2 Mannose from the Green Alga Boodlea Coacta Is a Potent Entry Inhibitor of HIV-1 and Influenza Viruses. Sato, Y., M. Hirayama, K. Morimoto, N. Yamamoto, S. Okuyama, and K. Hori. Journal of Biological Chemistry, 2011. [Epub ahead of print]; PMID[21460211].
[Pubmed], HIV_0401-041410.
17. Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently under Development as Microbicides. Selhorst, P., A.C. Vazquez, K. Terrazas-Aranda, J. Michiels, K. Vereecken, L. Heyndrickx, J. Weber, M.E. Quinones-Mateu, K.K. Arien, and G. Vanham. Antimicrobial Agents and Chemotherapy, 2011. 55(4): p. 1403-1413; PMID[21282453].
[Pubmed], HIV_0401-041410.
18. Glu659leu Substitution of Recombinant Hiv Fusion Inhibitor C52l Induces Soluble Expression in Escherichia Coli with Equivalent Anti-HIV Potency. Shang, S., S. Tan, K. Li, J. Wu, H. Lin, S. Liu, and Y. Deng. Protein Engineering, Design and Selection, 2011. [Epub ahead of print]; PMID[21478177].
[Pubmed], HIV_0401-041410.
19. Identification and Characterization of Incb9471, an Allosteric Non-Competitive Small Molecule Antagonist of Ccr5 with Potent Inhibitory Activity against Monocyte Migration and HIV-1 Infection. Shin, N., K. Solomon, N. Zhou, K.H. Wang, V. Garlapati, B. Thomas, Y. Li, M. Covington, F. Baribaud, S. Erickson-Viitanen, P. Czerniak, N. Contel, P. Liu, T. Burn, G. Hollis, S. Yeleswaram, K. Vaddi, C.B. Xue, B. Metcalf, S. Friedman, P. Scherle, and R. Newton. Journal of Pharmacology and Experimental TherapeuticsTher, 2011. [Epub ahead of print]; PMID[21459966].
[Pubmed], HIV_0401-041410.
20. Single-Nucleotide Changes in the HIV Rev-Response Element Mediate Resistance to Compounds That Inhibit Rev Function. Shuck-Lee, D., H. Chang, E.A. Sloan, M.L. Hammarskjold, and D. Rekosh. The Journal of Virology, 2011. 85(8): p. 3940-3949; PMID[21289114].
[Pubmed], HIV_0401-041410.
21. Viral Surface Glycoproteins, Gp120 and Gp41, as Potential Drug Targets against HIV-1: Brief Overview One Quarter of a Century Past the Approval of Zidovudine, the First Anti-Retroviral Drug. Teixeira, C., J.R. Gomes, P. Gomes, and F. Maurel. European Journal of Medicinal Chemistry, 2011. 46(4): p. 979-992; PMID[21345545].
[Pubmed], HIV_0401-041410.
22. The Role of Conserved Glu Residue on Cyclotide Stability and Activity: A Structural and Functional Study of Kalata B12, a Naturally Occurring Glu to Asp Mutant. Wang, C.K., R.J. Clark, P. Harvey, K.J. Rosengren, M. Cemazar, and D.J. Craik. Biochemistry, 2011. [Epub ahead of print]; PMID[21466163].
[Pubmed], HIV_0401-041410.
23. Analyses of Anti-Hiv Type 1 Activity of a Small Ccr5 Peptide Antagonist. Wang, F.Y., S.Y. He, Z.J. Zhang, L.F. He, X.W. Chen, and T. Teng. AIDS Res Hum Retroviruses, 2011. [Epub ahead of print]; PMID[21375388].
[Pubmed], HIV_0401-041410.
24. Novel Hiv-1 Non-Nucleoside Reverse Transcriptase Inhibitors: A Patent Review (2005 - 2010). Zhan, P. and X. Liu. Expert Opinion on Therapeutic Patents, 2011. [Epub ahead of print]; PMID[21457080].
[Pubmed], HIV_0401-041410.
25. Isolation and Characterization of a Kunitz-Type Trypsin Inhibitor with Antiproliferative Activity from Gymnocladus Chinensis (Yunnan Bean) Seeds Zhu, M.J., G.Q. Zhang, H.X. Wang, and T.B. Ng. The Protein Journal, 2011. [Epub ahead of print]; PMID[21468674].
[Pubmed], HIV_0401-041410.
ISI Web of Knowledge citations:
26. A New De Novo Approach for Optimizing Peptides That Inhibit Hiv-1 Entry. Fung, H.K., C.A. Floudas, M.S. Taylor, and R.F. Siliciano.17th European Symposium on Computer Aided Process Engineering, 2007. ISI[000287727400162].
[WOS], HIV_0401-041410.
27. Synthesis and Antiviral Activity of Some (3,4-Diaryl-3h-Thiazol-2-Ylidene)Pyrimidin-2-Yl Amine Derivatives. Turan-Zitouni, G., A. Ozdemir, and Z.A. Kaplancikli. Phosphorus Sulfur and Silicon and the Related Elements, 2011. 186(2): p. 233-239; ISI[000288370900005].
[WOS], HIV_0401-041410.
28. Synthesis, Cytostatic and Anti-Viral Activity Evaluation of the Novel Acyclic Nucleoside Analogues Containing a Sterically Constrained (Z)-4-Amino-2-Butenyl Moiety. Wittine, K., K. Benci, S.K. Pavelic, K. Pavelic, S. Bratulic, K. Hock, J. Balzarini, and M. Mintas. Medicinal Chemistry Research, 2011. 20(3): p. 280-286; ISI[000288398900003].
[WOS], HIV_0401-041410.
29. Screening and Evaluation of Thiourea Derivatives for Their Hiv Capsid and Human Cyclophilin a Inhibitory Activity. Tan, Z.W., J.B. Li, R.F. Pang, S.S. He, M.Z. He, S.X. Tang, I. Hewlett, and M. Yang. Medicinal Chemistry Research, 2011. 20(3): p. 314-320; ISI[000288398900008].
[WOS], HIV_0401-041410.
30. Bioactive Triterpenoids from Kadsura Heteroclita. Xu, L.J., Z.G. Peng, H.S. Chen, J. Wang, and P.G. Xiao. Chemistry & Biodiversity, 2010. 7(9): p. 2289-2295; ISI[000288457500010].
[WOS], HIV_0401-041410.
31. Various Biological Activities of Pyridazinone Ring Derivatives. Banerjee, P.S. Asian Journal of Chemistry, 2011. 23(5): p. 1905-1910; ISI[000288465200003].
[WOS], HIV_0401-041410.
32. Isolation and Characterization of Sesquiterpenoids from Daphne Acutiloba Rehd. He, S.Q., Z. Li, Y.W. Ou, L. Wang, G.Y. Yang, and Q.F. Hu. Asian Journal of Chemistry, 2011. 23(5): p. 2225-2226; ISI[000288465200086].
[WOS], HIV_0401-041410.
33. Synthesis and Anti-Hiv Activity of Beta-Cyclodextrin-C6-Sulfate/3-Azido-3 '-Deoxythymidine Inclusion Complex. Silion, M., A. Dascalu, B.C. Simionescu, M. Pinteala, and C. Ungurenasu. Journal of Polymer Science Part a-Polymer Chemistry, 2011. 49(7): p. 1730-1733; ISI[000288517400025].
[WOS], HIV_0401-041410.
34. Phytochemicals and Biological Activities of Dipsacus Species. Zhao, Y.M. and Y.P. Shi. Chemistry & Biodiversity, 2011. 8(3): p. 414-430; ISI[000288564600002].
[WOS], HIV_0401-041410.
35. Strategies Towards Improving the Pharmacokinetic Profile of Epsilon-Substituted Lysinol-Derived Hiv Protease Inhibitors. Rajapakse, H.A., A.M. Walji, K.P. Moore, H. Zhu, A.W. Mitra, A.R. Gregro, E. Tinney, C. Burlein, S. Touch, B.L. Paton, S.S. Carroll, D.J. DiStefano, M.T. Lai, J.A. Grobler, R.I. Sanchez, T.M. Williams, J.P. Vacca, and P.G. Nantermet. ChemMedChem, 2011. 6(2): p. 253-257; ISI[000288568000004].
[WOS], HIV_0401-041410.
36. Blocking Semen-Mediated Enhancement of Hiv Infection by Amyloid-Binding Small Molecules. Kirchhoff, F. and J. Munch. Future Virology, 2011. 6(2): p. 183-186; ISI[000288640200010].
[WOS], HIV_0401-041410.
37. Synthesis and Antiviral Activity of N-9- 3-Fluoro-2-(Phosphonomethoxy)Propyl Analogues Derived from N-6-Substituted Adenines and 2,6-Diaminopurines. Baszczynski, O., P. Jansa, M. Dracinsky, B. Klepetarova, A. Holy, I. Votruba, E. de Clercq, J. Balzarini, and Z. Janeba. Bioorganic & Medicinal Chemistry, 2011. 19(7): p. 2114-2124; ISI[000288792400001].
[WOS], HIV_0401-041410.
38. Transition-Metal Complexes Based on a Sulfonate-Containing N-Donor Ligand and Their Use as Hiv Antiviral Agents. Garcia-Gallego, S., M.J. Serramia, E. Arnaiz, L. Diaz, M.A. Munoz-Fernandez, P. Gomez-Sal, M.F. Ottaviani, R. Gomez, and F.J. de la Mata. European Journal of Inorganic Chemistry, 2011(10): p. 1657-1665; ISI[000288855100018].
[WOS], HIV_0401-041410.